Venous thromboembolic prophylaxis after a hepatic resection: Patterns of care among liver surgeons

HPB

Volumn 16, Issue 10, 2014, Pages 892-898

  Weiss, Matthew J ^a   Kim, Yuhree ^a   Ejaz, Aslam ^a   Spolverato, Gaya ^a   Haut, Elliott R ^a   Hirose, Kenzo ^a   Wolfgang, Christopher L ^a   Choti, Michael A ^a   Pawlik, Timothy M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; FIBRINOLYTIC AGENT;

ARTICLE; COMPRESSION INSTRUMENT; FEMALE; GASTROINTESTINAL SURGERY; HEPATOPANCREATOBILIARY SURGERY; HOSPITAL DISCHARGE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER FAILURE; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; SURGICAL TRAINING; THROMBOCYTOPENIA; THROMBOSIS PREVENTION; UNITED STATES; VENOUS THROMBOEMBOLISM; ADVERSE EFFECTS; BLEEDING; CHEMICALLY INDUCED; CLINICAL PRACTICE; CONSENSUS; DRUG ADMINISTRATION; HEALTH CARE SURVEY; INTERNET; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; STANDARDS; TIME; TREATMENT OUTCOME; TRENDS;

CONSENSUS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FIBRINOLYTIC AGENTS; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HEMORRHAGE; HEPATECTOMY; HUMANS; INTERNET; MALE; PRACTICE GUIDELINES AS TOPIC; PRACTICE PATTERNS, PHYSICIANS'; RISK ASSESSMENT; RISK FACTORS; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; VENOUS THROMBOEMBOLISM;

EID: 84927797498     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/hpb.12278     Document Type: Article

References (25)

1. Collins R, Scrimgeour A, Yusuf S, Peto R. (1988) Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med 318:1162-1173.
2. Mismetti P, Laporte S, Darmon JY, Buchmuller A, Decousus H. (2001) Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg 88:913-930.
3. Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA et al. (2012) Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl.):e227S-e277S.
4. Lyman GH, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP et al. (2013) Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31:2189-2204.
5. Caprini JA, Arcelus JI, Hasty JH, Tamhane AC, Fabrega F. (1991) Clinical assessment of venous thromboembolic risk in surgical patients. Semin Thromb Hemost 17(Suppl 3):304-312.
6. Ejaz A, Spolverato G, Kim Y, Lucas DL, Lau B, Weiss M et al. (2013) Defining incidence and risk factors of venous thromboemolism after hepatectomy. J Gastrointest Surg. Epub ahead of print.
7. De Martino RR, Goodney PP, Spangler EL, Wallaert JB, Corriere MA, Rzucidlo EM et al. (2012) Variation in thromboembolic complications among patients undergoing commonly performed cancer operations. J Vasc Surg 55:1035-1040 e4.
8. Barton JS, Riha GM, Differding JA, Underwood SJ, Curren JL, Sheppard BC et al. (2013) Coagulopathy after a liver resection: is it over diagnosed and over treated? HPB. Epub ahead of print.
9. Nathan H, Weiss MJ, Soff GA, Stempel M, Dematteo RP, Allen PJ et al. (2013) Pharmacologic prophylaxis, postoperative INR, and risk of venous thromboembolism after hepatectomy. J Gastrointest Surg 18:295-302.
10. Tzeng CW, Katz MH, Fleming JB, Pisters PW, Lee JE, Abdalla EK et al. (2012) Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patients. HPB 14:506-513.
11. Tripodi A, Mannucci PM. (2011) The coagulopathy of chronic liver disease. N Engl J Med 365:147-156.
12. Lisman T, Porte RJ. (2010) Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood 116:878-885.
13. Kucirka LM, Namuyinga R, Hanrahan C, Montgomery RA, Segev DL. (2009) Formal policies and special informed consent are associated with higher provider utilization of CDC high-risk donor organs. Am J Transplant 9:629-635.
14. Nathan H, Bridges JF, Schulick RD, Cameron AM, Hirose K, Edil BH et al. (2011) Understanding surgical decision making in early hepatocellular carcinoma. J Clin Oncol 29:619-625.
15. Morris-Stiff G, White A, Gomez D, Toogood G, Lodge JP, Prasad KR. (2008) Thrombotic complications following liver resection for colorectal metastases are preventable. HPB 10:311-314.
16. Reddy SK, Turley RS, Barbas AS, Steel JL, Tsung A, Marsh JW et al. (2011) Post-operative pharmacologic thromboprophylaxis after major hepatectomy: does peripheral venous thromboembolism prevention outweigh bleeding risks? J Gastrointest Surg 15:1602-1610.
17. Tzeng CW, Curley SA, Vauthey JN, Aloia TA. (2013) Distinct predictors of pre-versus post-discharge venous thromboembolism after hepatectomy: analysis of 7621 NSQIP patients. HPB 15:773-780.
18. Turley RS, Reddy SK, Shortell CK, Clary BM, Scarborough JE. (2012) Venous thromboembolism after hepatic resection: analysis of 5, 706 patients. J Gastrointest Surg 16:1705-1714.
19. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P et al. (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336:924-926.
20. Guyatt GH, Oxman AD, Kunz R, Falck-Ytter Y, Vist GE, Liberati A et al. (2008) Going from evidence to recommendations. BMJ 336:1049-1051.
21. Farge D, Debourdeau P, Beckers M, Baglin C, Bauersachs RM, Brenner B et al. (2013) International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. J Thromb Haemost 11:56-70.
22. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a doubleblind randomized multicentre trial with venographic assessment. ENOXACAN Study Group. (1997) Br J Surg 84:1099-1103.
23. Baykal C, Al A, Demirtas E, Ayhan A. (2001) Comparison of enoxaparin and standard heparin in gynaecologic oncologic surgery: a randomised prospective double-blind clinical study. Eur J Gynaecol Oncol 22:127-130.
24. McLeod RS, Geerts WH, Sniderman KW, Greenwood C, Gregoire RC, Taylor BM et al. (2001) Subcutaneous heparin versus low-molecularweight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the canadian colorectal DVT prophylaxis trial: a randomized, double-blind trial. Ann Surg 233:438-444.
25. Akl EA, Labedi N, Terrenato I, Barba M, Sperati F, Sempos EV et al. (2011) Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer. Cochrane Database Syst Rev (11): CD009447.